Edap Tms SA (NASDAQ:EDAP) has been assigned a consensus broker rating score of 1.00 (Strong Buy) from the one brokers that cover the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a strong buy recommendation.
Analysts have set a 12 month consensus price target of $6.50 for the company and are anticipating that the company will post ($0.03) EPS for the current quarter, according to Zacks. Zacks has also given Edap Tms an industry rank of 88 out of 257 based on the ratings given to related companies.
Several equities analysts recently weighed in on the stock. Zacks Investment Research raised shares of Edap Tms from a “sell” rating to a “hold” rating in a research note on Tuesday. HC Wainwright restated a “buy” rating on shares of Edap Tms in a research report on Tuesday, September 4th. ValuEngine upgraded shares of Edap Tms from a “hold” rating to a “buy” rating in a research report on Monday, July 16th. Finally, TheStreet cut shares of Edap Tms from a “c” rating to a “d+” rating in a research report on Friday, September 28th.
A hedge fund recently bought a new stake in Edap Tms stock. Fosun International Ltd bought a new stake in Edap Tms SA (NASDAQ:EDAP) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 170,627 shares of the medical equipment provider’s stock, valued at approximately $526,000. Fosun International Ltd owned about 0.59% of Edap Tms at the end of the most recent reporting period. 8.13% of the stock is owned by institutional investors and hedge funds.
NASDAQ EDAP traded down $0.09 on Friday, reaching $2.41. The company had a trading volume of 56,478 shares, compared to its average volume of 30,830. The company has a market capitalization of $72.49 million, a price-to-earnings ratio of -241.00 and a beta of 0.74. Edap Tms has a fifty-two week low of $2.07 and a fifty-two week high of $4.25. The company has a quick ratio of 1.97, a current ratio of 2.41 and a debt-to-equity ratio of 0.07.
Edap Tms (NASDAQ:EDAP) last announced its quarterly earnings results on Wednesday, August 29th. The medical equipment provider reported ($0.03) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.02) by ($0.01). The business had revenue of $10.14 million during the quarter, compared to the consensus estimate of $10.74 million. Edap Tms had a negative net margin of 3.55% and a negative return on equity of 2.66%. Research analysts expect that Edap Tms will post -0.03 earnings per share for the current fiscal year.
About Edap Tms
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS).
See Also: Exchange-Traded Funds (ETFs)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.